Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from SPOBAG AG ( (DE:LEOW) ) is now available.
SGCI Corporate Finance GmbH, a financial services firm based in Frankfurt, has acquired control of Leo International Precision Health Aktiengesellschaft, a company identified by ISIN DE0005490601. This acquisition involves SGCI holding 4.20% and Mr. Hsiao-Hsuan ‘Leo’ Wang holding 80.00% of the voting rights, with a combined total of 84.20% due to an acting in concert agreement. The acquisition signifies a strategic move by SGCI and Mr. Wang, with Mr. Ding-Shin Chang, the sole shareholder of SGCI, also indirectly gaining control. Following this acquisition, SGCI is set to make a mandatory offer to the remaining shareholders for their shares at the statutory minimum price, pending approval by the German Federal Financial Supervisory Authority.
More about SPOBAG AG
Average Trading Volume: 223
Technical Sentiment Signal: Buy
Current Market Cap: €4.25M
For a thorough assessment of LEOW stock, go to TipRanks’ Stock Analysis page.